Casi Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.15

+0.01 (+3.57%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +27,575.9% upside

Low Target $29.11

Average Target $40.13

High Target $50.28

Current Price $0.15

Current
$0.15

Target
$40.13

$29.11 $40.13 avg $50.28

Scenario Analysis

Bear Case

$29.11

19,975.9%

Low target

Base Case

$40.13

+27,575.9%

Avg target

Bull Case

$50.28

+34,575.9%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.48

-90.2% from high

52-Week Low

$0.05

+190.0% from low

Target vs 52W High

$40.13

+2,611.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%